Ethics and Malpractice Statement
Annals of Clinical Hypertension is committed to maintaining the highest standards of ethical publishing practices and preventing research misconduct.
The editorial team of Annals of Clinical Hypertension is committed to fair and unbiased evaluation of all submitted manuscripts. Editors make decisions based solely on scientific merit, significance, and appropriateness for the journal's scope, without regard to race, gender, nationality, religion, or institutional affiliation of the authors.
Editors maintain strict confidentiality regarding submitted manuscripts and do not disclose any information about submissions to anyone other than the corresponding author, reviewers, and editorial staff as appropriate.
Authors are responsible for ensuring that their work is original and has not been published elsewhere. All sources must be properly cited and acknowledged. Authors must disclose any potential conflicts of interest and ensure that all listed co-authors have contributed significantly to the work and have approved the final manuscript.
Fabrication, falsification, or plagiarism in any form is strictly prohibited and will result in immediate rejection and potential sanctions.
Reviewers are expected to provide objective, constructive, and timely reviews. All reviewers must maintain confidentiality and not use any information from the manuscript for personal advantage. Reviewers should declare any conflicts of interest and recuse themselves when appropriate.
The peer review process is conducted with utmost integrity to ensure fair evaluation and maintain the quality of published research.
Any form of plagiarism, including self-plagiarism, is unacceptable. All submissions are screened using advanced plagiarism detection software.
Fabrication or falsification of research data is strictly prohibited and will result in immediate rejection and reporting to relevant institutions.
Manuscripts should not be submitted simultaneously to multiple journals. Prior publication elsewhere must be disclosed.
All listed authors must have made substantial contributions. Guest authorship and ghost authorship are not permitted.
If you suspect research misconduct or ethical violations, please contact our editorial office immediately. All reports will be investigated promptly and confidentially in accordance with established procedures.
We are committed to maintaining the integrity of the scientific record and will take appropriate action against any verified misconduct.
Annals of Clinical Hypertension is dedicated to upholding the highest standards of research integrity and ethical publishing practices. We continuously review and update our policies to ensure compliance with international standards and best practices in scholarly publishing.